Cytokines as intrinsic and exogenous regulators of pathogenesis in experimental autoimmune encephalomyelitis

Research in Immunology

Volumn 149, Issue 9, 1998, Pages

  Smith Begolka, W ^a   Miller, Stephen D ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CENTRAL NERVOUS SYSTEM; DEMYELINATING DISEASE; DISEASE COURSE; DOWN REGULATION; HELPER CELL; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; RAT; REMISSION; REVIEW;

EID: 0042138931     PISSN: 09232494     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-2494(99)80004-2     Document Type: Article

References (102)

1. Ando, D.G., Clayton, J., Kono, D., Urban, J.L. & Sercarz, E.E. (1989), Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype. Cell. Immunol., 124, 132-143.
2. Baker, D., O'Neill, J.K. & Turk, J.L. (1991), Cytokines in the central nervous system of mice during chronic relapsing experimental allergic encephalomyelitis. Cell. Immunol., 134, 505-510.
3. Baron, J.L., Madri, J.A., Ruddle, N.H., Hashim, G. & Janeway, C. A. (1993), Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma. J. Exp. Med., 177, 57-68.
4. Bebo, B.F.J., Vandenbark, A.A. & Offner, H. (1996), Male SJL mice do not relapse after induction of EAE with PLP 139-151. J. Neurosci. Res., 45, 680-689.
5. Billiau, A., Heremans, H., Vandekerckhove, F., Dijkmans, R., Sobis, H., Meulepas, E. & Carton, H. (1988), Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-gamma. J. Immunol., 140, 1506-1510.
6. Bright, J.J., Musuro, B.F., Du, C. & Sriram, S. (1998), Expression of IL12 in CNS and lymphoid organs of mice with experimental allergic encephalitis. J. Neuroimmunol., 82, 22-30.
7. Brocke, S., Gijbels, K., Allegretta, M., Ferber, I., Piercy, C., Blankenstein, T., Martin, R., Utz, U., Karin, N., Mitchell, D., Veromaa, T., Waisman, A., Gaur, A., Conlon, P., Ling, N., Fairchild, P.J., Wraith, D.C., O'Garra, A., Fathman, C.G. & Steinman, L. (1996), Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature, 379, 343-346.
8. Browning, J.L., Majeau, G.R. & Mackay, F. (1995), Proinflammatory responses are efficiently induced by homotrimeric but not heterotrimeric lymphotoxin ligands. J. Inflam., 46, 220-234.
9. Cannella, B., Gao, Y.L., Brosnan, C. & Raine, C.S. (1996), IL-10 fails to abrogate experimental autoimmune encephalomyelitis. J. Neurosci. Res., 45, 735-746.
10. Cannella, B. & Raine, C.S. (1995), The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann. Neurol., 37, 424-435.
11. Chen, Y., Kuchroo, V.K., Inobe, J., Hafler, D.A. & Weiner, H.L. (1994), Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science, 265, 1237-1240.
12. Crisi, G.M., Santambrogio, L., Hochwald, G.M., Smith, S.R., Carlino, J.A. & Thorbecke, G.J. (1995), Staphylococcal enterotoxin B and tumor-necrosis factor-alpha-induced relapses of experimental allergic encephalomyelitis : protection by transforming growth factor-beta and interleukin-10. Eur. J. Immunol., 25, 3035-3040.
13. Cross, A.H., Misko, T.P., Lin, R.F., Hickey, W.F., Trotter, J.L. & Tilton, R.G. (1994), Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J. Clin. Invest., 93, 2684-2690.
14. Duong, T.T., Finkelman, F.D., Singh, B. & Strejan, G.H. (1994), Effect of anti-interferon-gamma monoclonal antibody treatment on the development of experimental allergic encephalomyelitis in resistant mouse strains. J. Neuroimmunol., 53, 101-107.
15. Duong, T.T., St Gilbert, J.J., Finkelman, F.D. & Strejan, G.H. (1992), Effect of anti-interferon-gamma and anti-interleukin-2 monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse. J. Neuroimmunol., 36, 105-115.
16. Falcone, M. & Bloom, B.R. (1997), A T helper cell 2 (Th2) immune response against non-self antigens modifies the cytokine profile of autoimmune T cells and protects against experimental allergic encephalomyelitis. J. Exp. Med., 185, 901-907.
17. Falcone, M., Rajan, A.J., Bloom, B.R. & Brosnan, C.F. (1998), A critical role for IL-4 in regulating disease severity in experimental allergic encephalomyeltis as demonstrated in IL-4-deficient C57BL/6 and BALB/c mice. J. Immunol., 160, 4822-4830.
18. Ferber, I.A., Brocke, S., Taylor-Edwards, C., Ridgway, W., Dinisco, C., Steinman, Dalton, D. & Fathman, C.G. (1996), Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol., 156, 5-7.
19. Fiorentino, D.F., Bond, M.W. & Mosmann, T.R. (1989), Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med., 170, 2081-2095.
20. Fiorentino, D.F., Zlotnik, A., Mosman, T.R., Howard, M.H. & O'Garra, A. (1991), IL-10 inhibits cytokine production by activated macrophages. J. Immunol., 147, 3815-3822.
21. Frei, K., Eugster, H.P., Bopst, M., Constantinescu, C.S., Lavi, E. & Fontana, A. (1998), Tumor necrosis factor alpha and lymphotoxin alpha are not required for induction of acute experimental autoimmune encephalomyelitis. J. Exp. Med., 185, 2177-2182.
22. Frei, K., Lins, H., Schwerdel, C. & Fontana, A. (1994), Antigen presentation in the central nervous system. The inhibitory effect of IL-10 on MHC Class II expression and production of cytokines depends on the inducing signals and the type of cell analyzed. J. Immunol., 152, 2720-2728.
23. Germann, T., Szeliga, J., Hess, H., Storkel, S., Podlaski, F.J., Gately, M.K., Schmitt, E. & Rude, E. (1995), Administration of interleukin-12 in combination with type ii collagen induces severe arthritis in DBA/1 mice. Proc Natl. Acad. Sci. U. S. A., 92, 4823-4827.
24. Gordon, K.B., Girvin, A.M., Tan, L.J., Nikcevich, K.M., Welsh, C.J., Clipstone, N.A. & Miller, S.D. (1998), Differential activation of murine T lymphocytes by central nervous system-resident endothelial cells and astrocytes. J. Immunol, (in press).
25. Held, W., Meyermann, R., Qin, Y. & Mueller, C. (1993), Perforin and tumor necrosis factor alpha in the pathogenesis of experimental allergic encephalomyelitis: comparison of autoantigen induced and transferred disease in Lewis rats. J. Autoimmun., 6, 311-322.
26. Heremans, H., Dillen, C., Groenen, M., Martens, E. & Billiau, A. (1996), Chronic relapsing experimental autoimmune encephalomyelitis (CREAE) in mice : enhancement by monoclonal antibodies against interferon-gamma. Eur. J. Immunol., 26, 2393-2398.
27. Inobe, J.I., Chen, Y. & Weiner, H.L. (1996), In vivo administration of IL-4 induces TGF-beta-producing cells and protects animals from experimental autoimmune encephalomyelitis. Ann. NY Acad. Sci., 778, 390-392.
28. Issazadeh, S., Ljungdahl, A., Hojeberg, B., Mustafa, M. & Olsson, T. (1995), Cytokine production in the central nervous system of Lewis rats with experimental autoimmune encephalomyelitis : dynamics of mRNA expression for IL-10, interleukin-12, cytolysin, tumor necrosis factor alpha, and tumor necrosis beta. J. Neuroimmunol., 61, 205-212.
29. Issazadeh, S., Lorentzen, J.C., Mustafa, M.I., Hojeberg, B., Mussener, A. & Olsson (1996), Cytokines in relapsing experimental autoimmune encephalomyelitis in DA rats : persistent mRNA expression of proinflammatory cytokines and absent expression of interleukin-10 and transforming growth factor-beta. J. Neuroimmunol., 69, 103-115.
30. Issazadeh, S., Mustafa, M., Ljungdahl, A., Hojeberg, B., Dagerlind, A., Elde, R. & Olsson, T. (1995), Interferon gamma, interleukin 4 and transforming growth factor beta in experimental autoimmune encephalomyelitis in Lewis rats : dynamics of cellular mRNA expression in the central nervous system and lymphoid cells. J. Neurosci. Res., 40, 579-590.
31. Johns, L.D., Flanders, K.C., Ranges, G.E. & Sriram, S. (1991), Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-beta 1. J. Immunol., 147, 1792-1796.
32. + suppressor cells of autoimmune encephalomyelitis respond to T cell receptor-associated determinants on effector cells by interleukin-4 secretion. Eur. J. Immunol., 22, 1757-1763.
33. Karpus, W.J., Kennedy, K.J., Smith, W.S. & Miller, S.D. (1996), Inhibition of relapsing experimental autoimmune encephalomyelitis in SJL mice by feeding the irnmunodominant PLP139-151 molecule. J. Neurosci. Res., 45, 410-423.
34. + suppressor cells inhibit the function of effector cells of experimental autoimmune encephalomyelitis through a mechanism involving transforming growth factor-beta. J. Immunol., 146, 1163-1168.
35. Kasama, T., Strieter, R.M., Lukacs, N.W., Lincoln, P.M., Burdick, M.D. & Kunkel, S.L. (1995), Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis. J. Clin. Invest., 95, 2868-2876.
36. Kennedy, M.K., Torrance, D.S., Picha, K.S. & Mohler, K.M. (1992), Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J. Immunol., 149, 2496-2505.
37. Khoruts, A., Miller, S.D. & Jenkins, M.K. (1995), Neuroantigen-specific Th2 cells are inefficient suppressors of experimental autoimmune encephalomyelitis induced by effector Th1 cells. J. Immunol., 155, 5011-5017.
38. Khoury, S.J., Hancock, W.W. & Weiner, H.L. (1992), Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and protaglandin E expression in the brain. J. Exp. Med., 176(5), 1355-1364.
39. Klinkert, W.E., Kojima, K., Lesslauer, W., Rinner, W., Lassmann, H. & Wekerle, H. (1997), TNF-alpha receptor fusion protein prevents experimental autoimmune encephalomyelitis and demyelination in Lewis rats : an overview. J. Neuroimmunol., 72, 163-168.
40. 2 cytokine responses. Nature, 362, 245-250.
41. Korner, H., Lemckert, P.A., Chaudhri, G., Etteldorf, S. & Sedgewick, J.D. (1997a), Tumor necrosis factor blockade in actively induced experimental autoimmune encephalomyelitis prevents clinical disease despite activated T cell infiltration to the central nervous system. Eur. J. Immunol., 27, 1973-1981.
42. Korner, H., Riminton, D.S., Strickland, D.H., Lemckert, F.A., Pollard, J.D. & Sedgewick, J.D. (1997b), Critical points of tumor necrosis factor action in central nervous system autoimmune inflammation defined by gene targeting. J. Exp. Med., 186, 1585-1590.
43. Krakowski, M. & Owens, T. (1996), Interferon-gamma confers resistance to experimental allergic encephalomyelitis. Eur. J. Immunol., 26, 1641-1646.
44. Kuchroo, V.K., Das, M.P., Brown, J.A., Ranger, A.M., Zamvil, S.S., Sobel, R.A., Weiner, H.L., Nabavi, N. & Glimcher, L.H. (1995), B7-1 and B7-2 costimulatory molecules differentially activate the Th1/Th2 developmental pathways: Application to autoimmune disease therapy. Cell, 80, 707-718.
45. Kuroda, Y. & Shimamoto, Y. (1991), Human tumor necrosis factor-a augments experimental allergic encephalomyelitis in rats. J. Neuroimmunol., 34, 159-164.
46. Kuruvilla, A.P., Shah, R., Hochwald, G.M., Liggitt, H.D., Palladino, M.A. & Thorbecke, G.J. (1991), Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice. Proc. Natl. Acad. Sci. USA, 88, 2918-2921.
47. Kühn, R., Rajewsky, K. & Müller, W. (1991), Generation and analysis of interleukin-4 deficient mice. Science., 254, 707-710.
48. Lafaille, J.J., Van de Keere, F., Hsu, A.L., Baron, J.L., Haas, W., Raine, C.S. & Tonegawa, S. (1997), Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease. J. Exp. Med., 186, 307-312.
49. Leonard, J.P., Waldburger, K.E. & Goldman, S.J. (1995), Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J. Exp. Med., 181, 381-386.
50. Leonard, J.P., Waldburger, K.E. & Goldman, S.J. (1996), Regulation of experimental autoimmune encephalomyelitis by interleukin-12. Ann NY Acad Sci, 795, 216-226.
51. Liblau, R., Steinman, L. & Brocke, S. (1997), Experimental autoimmune encephalomyelitis in IL-4-deficient mice. Int. Immunol., 9, 799-803.
52. Link, J., (1994), Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis. Acta Neurologica Scandinavia, Supplementum. 158, 1-58.
53. Link, J., Soderstrom, M., Ljungdahl, A., Hojeberg, B., Olsson, T., Xu, Z., Fredrikson, S., Wang, Z.Y. & Link, H. (1994), Organ-specific autoantigens induce interferon-gamma and interleukin-4 mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis. Neurology, 44, 728-734.
54. Liu, J., Marino, M.W., Wong, G., Grail, D., Dunn, A., Bettadapurs, J., Slavin, A.J., Old, L. & Bernard, C.C.A. (1998), TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nature Med., 4, 78-83.
55. Lublin, F.D., Knobler, R.L., Kalman, B., Goldhaber, M., Marini, J., Perrault, M., D'Imperio, C., Joseph, J., Alkan, S.S. & Komgold, R. (1993), Monoclonal antigamma interferon antibodies enhance experimental allergic encephalomyelitis. Autoimmunity, 16, 267-274.
56. Martin, D., Near, S.L., Bendele, A. & Russell, D.A. (1995), Inhibition of tumor necrosis factor is protective against neurologic dysfunction after active immunization of Lewis rats with myelin basic protein. Exp. Neurol., 131, 221-228.
57. Mathisen, P.M., Yu, M., Johnson, J.M., Drazba, J.A. & Touhy, V.K. (1997), Treatment of experimental autoimmune encephalomyelitis with genetically modified memory T cells. J. Exp. Med., 186, 159-164.
58. McRae, B.L., Vanderlugt, C.L., Dal Canto, M.C. & Miller, S.D. (1995), Functional evidence for epitope spreading in the relapsing pathology of EAE in the SJL/J mouse. J. Exp. Med., 182, 75-85.
59. Merrill, J.E., Ignarro, L.J., Sherman, M.P., Melinek, J. & Lane, T.E. (1993), Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol., 151, 2132-2141.
60. Merrill, J.E., Kono, D.H., Clayton, J., Ando, D.G., Hinton, D.R. & Hofman, F.M. (1992), Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice. Proc. Natl Acad. Sci. USA, 89, 574-578.
61. Mosmann, T.R. & Coffman, R.L. (1989), Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties. Ann. Rev. Immunol., 7, 145-174.
62. Mueller, R., Krahl, T. & Sarvetnick, N. (1996), Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice. J. Exp. Med., 184, 1093-1099.
63. Navikas, V. & Link, H. (1996), Review: cytokines and the pathogenesis of multiple sclerosis. J. Neurosci. Res., 45, 322-333.
64. Oswald, I.P., Wynn, T.A., Sher, A. & James, S.J. (1992), Interleukin-10 inhibits macrophage microbial activity by blocking the endogenous production of tumor necrosis factor alpha required as a costimulatory factor for interferon-gamma-induced activation. Proc. Natl. Acad. Sci. USA, 89, 8676-8680.
65. Panitch, H.S. & Bever, C.T., Jr. (1993), Clinical trials of interferons in multiple sclerosis. What have we learned? J. Neuroimmunol., 46, 155-164.
66. Powell, M.B., Mitchell, D., Lederman, J., Buckmeier, J., Zamvil, S.S., Graham, M., Ruddle, N.H. & Steinman, L. (1990), Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity. Int. Immunol., 2, 539-544.
67. Probert, L., Akassoglou, K., Pasparakis, M., Kontogeorgos, G. & Kollias, G. (1995), Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor-alpha. Proc. Natl. Acad. Sci. USA, 92, 11294-11298.
68. Racke, M.K., Bonomo, A., Scott, D.E., Cannella, B., Levine, A., Raine, C.S., Shevach, E.M. & Rocken, M. (1994), Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med., 180, 1961-1966.
69. Racke, M.K., Cannella, B., Albert, P., Sporn, M., Raine, C.S. & McFarlin, D.E. (1992), Evidence of endogenous regulatory function of transforming growth factor-beta 1 in experimental allergic encephalomyelitis. Int. Immunol., 4, 615-620.
70. Racke, M.K., Dhib-Jalbut, S., Cannella, B., Albert, P.S., Raine, C.S. & McFarlin, D.E. (1991), Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1. J. Immunol., 146, 3012-3017.
71. Renno, T., Krakowski, M., Piccirillo, C., Lin, J.Y. & Owens, T. (1995), TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines, J. Immunol., 154, 944-953.
72. + T cells in autoimmune infiltrates in experimental allergic encephalomyelitis. Int. Immunol., 6, 347-354.
73. Rieckmann, P., Albrecht, M., Kitze, B., Weber, T., Tumani, H., Broocks, A., Luer & Poser, S. (1994), Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis. Neurology, 44, 1523-1526.
74. Riminton, D.S., Korner, H., Strickland, D.H., Lemckert, F.A., Pollard, J.D. & Sedgewick, J.D. (1998), Challenging cytokine redundancy : Inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxin-deficient, but not tumor necrosis factor-deficient mice. J. Exp. Med., 187, 1517-1528.
75. Rott, O., Fleischer, B. & Cash, E. (1994), Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur. J. Immunol., 24, 1434-1440.
76. Ruddle, N.H., Bergman, C.M., McGrath, K.M., Lingenheld, E.G., Grunnet, M.L., Padula, S.J. & Clark, R.B. (1990), An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J. Exp. Med., 172, 1193-1200.
77. Schluesener, H.J., (1990), Transforming growth factors type beta 1 and beta 2 suppress rat astrocyte autoantigen presentation and antagonize hyperinduction of class II major histocompatibility complex antigen expression by interferon-gamma and tumor necrosis factor-alpha. J. Neuroimmunol., 27, 41-47.
78. Schluesener, H.J. & Lider, O. (1989), Transforming growth factors beta 1 and beta 2 : cytokines with identical immunosuppressive effects and a potential role in the regulation of autoimmune T cell function. J. Neuroimmunol., 24, 249-258.
79. Segal, B.M., Dwyer, B.K. & Shevach, E.M. (1998), An Interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J. Exp. Med., 187, 537-546.
80. Segal, B.M. & Shevach, E.M. (1996), IL-12 unmasks latent autoimmune disease in resistant mice. J. Exp. Med., 184, 771-775.
81. Selmaj, K., Papierz, W., Glabinski, A. & Kohno, T. (1995), Prevention of chronic relapsing experimental autoimmune encephalomyelitis by soluble tumor necrosis factor receptor I. J. Neuroimmunol., 56, 135-141.
82. Selmaj, K., Raine, C.S., Cannella, B. & Brosnan, C.F. (1991c), Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J. Clin. Invest., 87, 949-954.
83. Selmaj, K., Raine, C.S. & Cross, A.M. (1991a), Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann. Neurol., 30, 694-700.
84. Selmaj, K., Raine, C.S., Farooq, M., Norton, W.T. & Brosnan, C.F. (1991b), Cytokine cytotoxicity against oligodendrocytes. Apoptosis induced by lymphotoxin. J. Immunol., 147, 1522-1529.
85. Selmaj, K.W. & Raine, C.S. (1988), Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol., 23, 339-346.
86. Shaw, M.K., Lorens, J.B., Dhawan, A., DalCanto, R., Tse, H.Y., Tran, A.B., Bonpane, C., Eswaran, S.L., Brocke, S., Sarvetnick, N., Steinman, L., Nolan, G.P. & Fathman, C.G. (1997), Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis. J. Exp. Med., 185, 1711-1714.
87. Shull, M.M., Ormsby, I., Kier, A.B., Pawlowski, S., Diebold, R.J., Yin, M., Allen, R., Sidman, C., Proetzel, G., Calvin, D., Annunziata, N. & Doetschman, T. (1992), Targeted disruption of the mouse transforming growth factor-gene results in multifocal inflammatory disease. Nature, 359, 693-699.
88. Smith Begolka, W., Vanderlugt, C.L., Rahbe, S.M. & Miller, S.D. (1998), Differential expression of inflammatory cytokines parallels progression of CNS pathology in two clinically distinct models of MS. J. Immunol., 161, 4437-4446.
89. Smith, T., Hewson, A.K., Kingsley, C.I., Leonard, J.P. & Cuzner, M.L. (1997), Interleukin-12 induces relapse in experiemental allergic encephalomyelitis in the Lewis rat. Am. J. Pathol., 150, 1909-1917.
90. Suen, W.E., Bergman, C.M., Hjelmström, P. & Ruddle, N.H. (1997), A critical role for lymphotoxin in experimental allergic encephalomyelitis. J. Exp. Med., 186, 1233-1240.
91. Tan, L.J., Gordon, K.B., Mueller, J.P., Matis, L.A. & Miller, S.D. (1998), Presentation of proteolipid protein epitopes and B7-1-dependent activation of encephalitogenic T cells by IFN-gamma-activated SJL/J astrocytes. J. Immunol., 160, 4271-4279.
92. Tanuma, N., Kojima, T., Shin, T., Aikawa, Y., Kohji, T., Ishihara, Y. & Matsumoto (1997), Competitive PCR quantification of pro-and anti-inflammatory cytokine mRNA in the central nervous system during autoimmune encephalomyelitis. J. Neuroimmunol., 73, 197-206.
93. Taupin, V., Renno, T., Bourbonniere, L., Peterson, A.C., Rodriguez, M. & Owens, T. (1997), Increased severity of experimental autoimmune encephalomyelitis, chronic macrophage/microglial reactivity, and demyelination in transgenic mice producing tumor necrosis factor-alpha in the central nervous system. Eur. J. Immunol., 27, 905-913.
94. Traugott, U. & Lebon, P. (1988), Demonstration of alpha, beta, and gamma interferon in active chronic multiple sclerosis lesions. Ann. N. Y. Acad. Sci., 540, 309-311.
95. Trembleau, S., Penna, G., Bosi, E., Mortara, A., Gately, M.K. & Adorini, L. (1995), Interleukin 12 induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J. Exp. Med., 181, 817-821.
96. van der Veen, R.C. & Stohlman, S.A. (1993), Encephalitogenic Th1 cells are inhibited by Th2 cells with related peptide specificity: relative roles of interleukin (IL)-4 and IL-10. J. Neuroimmunol., 48, 213-220.
97. Voorthuis, J.A.C., Uitdehaag, B.M.J., De Groot, C.J.A., Goede, P.M., van der Meide, P.M. & Dijkstra, C.D. (1990), Suppression of experimental allergic encephalomyelitis by intraventricular administration of interferon-gamma in Lewis rats. Clin. Exp. Immunol., 81, 183-188.
98. Voskuhl, R.R., Martin, R., Bergman, C., Dalal, M., Ruddle, N.H. & McFarland, H.F. (1993), T helper 1 (Th1) functional phenotype of human myelin-basic protein-specific T lymphocytes. Autoimmunity, 15, 137-143.
99. Willenborg, D.O., Fordham, S., Bernard, C.C., Cowden, W.B. & Ramshaw, I.A. (1996), IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J. Immunol., 157, 3223-3227.
100. Willenborg, D.O., Fordham, S.A., Cowden, W.B. & Ramshaw, I.A. (1995), Cytokines and murine autoimmune encephalomyelitis: inhibition or enhancement of disease with antibodies to select cytokines, or by delivery of exogenous cytokines using a recombinant vaccinia virus system. Scand. J. Immunol., 41, 31-41.
101. Windhagen, A., Newcombe, J., Dangond, F., Strand, C., Woodroofe, M.N., Cuzner, M.L. & Hafler, D.A. (1995), Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD80), and interleukin 12 cytokine in multiple sclerosis lesions. J. Exp. Med., 182, 1985-1996.
102. Wogensen, L., Lee, M.S. & Sarvetnick, N. (1994), Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic mice. J. Exp. Med., 179, 1379-1384.